Cargando…

Inflammatory bone marrow signaling in pediatric acute myeloid leukemia distinguishes patients with poor outcomes

High levels of the inflammatory cytokine IL-6 in the bone marrow are associated with poor outcomes in pediatric acute myeloid leukemia (pAML), but its etiology remains unknown. Using RNA-seq data from pre-treatment bone marrows of 1489 children with pAML, we show that > 20% of patients have concu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bolouri, Hamid, Ries, Rhonda E., Wiedeman, Alice E., Hylkema, Tiffany, Scheiding, Sheila, Gersuk, Vivian H., O’Brien, Kimberly, Nguyen, Quynh-Anh, Smith, Jenny L., Alice Long, S., Meshinchi, Soheil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684530/ https://www.ncbi.nlm.nih.gov/pubmed/36418348 http://dx.doi.org/10.1038/s41467-022-34965-4

Ejemplares similares

A B-cell developmental gene regulatory network is activated in infant AML
por: Bolouri, Hamid, et al.
Publicado: (2021)

Long Noncoding RNA Expression Independently Predicts Outcome in Pediatric Acute Myeloid Leukemia
por: Farrar, Jason E., et al.
Publicado: (2023)

CBFB-MYH11 fusion transcripts distinguish acute myeloid leukemias with distinct molecular landscapes and outcomes
por: Huang, Benjamin J., et al.
Publicado: (2021)

Therapeutic Targeting of Mesothelin with Chimeric Antigen Receptor T Cells in Acute Myeloid Leukemia
por: Le, Quy, et al.
Publicado: (2021)

Expression and functional characterization of CD33 transcript variants in human acute myeloid leukemia
por: Laszlo, George S., et al.
Publicado: (2016)

Donor bone marrow–derived macrophage engraftment into the central nervous system of patients following allogeneic transplantion
por: Loeb, Anisha M., et al.
Publicado: (2023)

High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children’s Oncology Group
por: Laszlo, George S., et al.
Publicado: (2015)

Erratum to: High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children’s Oncology Group
por: Laszlo, George S., et al.
Publicado: (2016)

The many faces of islet antigen‐specific CD8 T cells: clues to clinical outcome in type 1 diabetes
por: Wiedeman, Alice E, et al.
Publicado: (2021)

Neuroinvasive West Nile Infection Elicits Elevated and Atypically Polarized T Cell Responses That Promote a Pathogenic Outcome
por: James, Eddie A., et al.
Publicado: (2016)

Consistent quantitative gene product expression: #1. Automated identification of regenerating bone marrow cell populations using support vector machines
por: Voigt, Andrew P., et al.
Publicado: (2016)

Transcriptome Profiling of Pediatric Core Binding Factor AML
por: Hsu, Chih-Hao, et al.
Publicado: (2015)

The clinical and biological characteristics of NUP98-KDM5A pediatric acute myeloid leukemia
por: Noort, Sanne, et al.
Publicado: (2020)

“FLipping” the Story: FLT3-Mutated Acute Myeloid Leukemia and the Evolving Role of FLT3 Inhibitors
por: Knight, Tristan E., et al.
Publicado: (2022)

SAMHD1 single nucleotide polymorphisms impact outcome in children with newly diagnosed acute myeloid leukemia
por: Marrero, Richard J., et al.
Publicado: (2023)

MicroRNA-150 Expression Induces Myeloid Differentiation of Human Acute Leukemia Cells and Normal Hematopoietic Progenitors
por: Morris, Valerie A., et al.
Publicado: (2013)

Consistent quantitative gene product expression: #2. Antigen intensities on bone marrow cells are invariant between individuals
por: Loken, Michael R., et al.
Publicado: (2016)

Time to reconsider CD33 single nucleotide polymorphism in the response to gemtuzumab ozogamicin
por: Lamba, Jatinder K., et al.
Publicado: (2021)

TNF-α and TGF-β Counter-Regulate PD-L1 Expression on Monocytes in Systemic Lupus Erythematosus
por: Ou, Jing-Ni, et al.
Publicado: (2012)

A transcriptomic reporter assay employing neutrophils to measure immunogenic activity of septic patients’ plasma
por: Khaenam, Prasong, et al.
Publicado: (2014)

Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leukemia
por: McNeer, Nicole A., et al.
Publicado: (2019)

Distinct Metabolic features differentiating FLT3-ITD AML from FLT3-WT childhood Acute Myeloid Leukemia
por: Stockard, Bradley, et al.
Publicado: (2018)

Distinct age-associated molecular profiles in acute myeloid leukemia defined by comprehensive clinical genomic profiling
por: Tarlock, Katherine, et al.
Publicado: (2018)

Development of siRNA-Loaded Lipid Nanoparticles Targeting Long Non-Coding RNA LINC01257 as a Novel and Safe Therapeutic Approach for t(8;21) Pediatric Acute Myeloid Leukemia
por: Connerty, Patrick, et al.
Publicado: (2021)

Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia
por: Braun, Theodore P., et al.
Publicado: (2019)

MicroRNA Expression-Based Model Indicates Event-Free Survival in Pediatric Acute Myeloid Leukemia
por: Lim, Emilia L., et al.
Publicado: (2017)

CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell target
por: Le, Quy, et al.
Publicado: (2022)

Author Correction: Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia
por: Braun, Theodore P., et al.
Publicado: (2022)

Clinical relevance of proteomic profiling in de novo pediatric acute myeloid leukemia: a Children’s Oncology Group study
por: Hoff, Fieke W., et al.
Publicado: (2022)

Selection of reliable reference genes for the normalisation of gene expression levels following time course LPS stimulation of murine bone marrow derived macrophages
por: Tanaka, Akane, et al.
Publicado: (2017)

Integrated stem cell signature and cytomolecular risk determination in pediatric acute myeloid leukemia
por: Huang, Benjamin J., et al.
Publicado: (2022)

Bone marrow lesions of the femoral head: can radiomics distinguish whether it is reversible?
por: Batur, Halitcan, et al.
Publicado: (2023)

Network deconvolution as a general method to distinguish direct dependencies in networks
por: Feizi, Soheil, et al.
Publicado: (2013)

MicroRNA Signatures in Blood or Bone Marrow Distinguish Subtypes of Pediatric Acute Lymphoblastic Leukemia
por: Nair, Rekha A, et al.
Publicado: (2020)

Preclinical studies targeting CD74 with STRO-001 antibody-drug conjugate in acute leukemia
por: Le, Quy, et al.
Publicado: (2023)

Responders to low-dose ATG induce CD4(+) T cell exhaustion in type 1 diabetes
por: Jacobsen, Laura M., et al.
Publicado: (2023)

Innate immune markers that distinguish red deer (Cervus elaphus) selected for resistant or susceptible genotypes for Johne’s disease
por: Dobson, Brooke, et al.
Publicado: (2013)

A Question of Frame: The Role of the Bone Marrow Stromal Niche in Myeloid Malignancies
por: Tomasoni, Chiara, et al.
Publicado: (2023)

Quality of life in pediatric acute myeloid leukemia: Report from the Children's Oncology Group
por: Nagarajan, Rajaram, et al.
Publicado: (2019)

Acute myeloid leukemia shapes the bone marrow stromal niche in vivo
por: Pievani, Alice, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kd9fjlqlv47nns6jt539vco66o